J. Martin Carroll
Director · Esperion Therapeutics, Inc.
Individual
- 2024
- Jul 13, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies J. Martin Carroll files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sheldon L. Koenig - $239K in ESPR purchases and sales in the last 12 months
- Benjamin Looker - $61K in ESPR purchases and sales in the last 12 months
- Benjamin Halladay - $51K in ESPR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is J. Martin Carroll?
J. Martin Carroll is a corporate insider, tracked as Director of Esperion Therapeutics, Inc. (ESPR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did J. Martin Carroll last file a Form 4?
The most recent primary Form 4 on record is dated 13 July 2026, one of 5 filings going back to 2024.
